These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29865170)

  • 21. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
    Mercadante S; Prestia G; Casuccio A
    Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variation of breakthrough pain in cancer patients.
    Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
    Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating cancer-related breakthrough pain: the oral transmucosal route.
    Laverty D
    Int J Palliat Nurs; 2007 Jul; 13(7):326-31. PubMed ID: 17851376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breakthrough pain in cancer patients: prevalence, mechanisms and treatment options.
    Mercadante S
    Curr Opin Anaesthesiol; 2015 Oct; 28(5):559-64. PubMed ID: 26263120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study.
    Pérez-Hernández C; Blasco A; Gándara Á; Mañas A; Rodríguez-López MJ; Martínez V; Fernandez-Nistal A; Montoto C
    Sci Rep; 2019 Nov; 9(1):17701. PubMed ID: 31776408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study.
    Løhre ET; Hjermstad MJ; Brunelli C; Knudsen AK; Kaasa S; Klepstad P
    Pain Ther; 2018 Dec; 7(2):193-203. PubMed ID: 30415462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain.
    Gómez-Batiste X; Madrid F; Moreno F; Gracia A; Trelis J; Nabal M; Alcalde R; Planas J; Camell H
    J Pain Symptom Manage; 2002 Jul; 24(1):45-52. PubMed ID: 12183094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.
    Mercadante S; Adile C; Masedu F; Valenti M; Aielli F
    J Pain Symptom Manage; 2019 May; 57(5):966-970. PubMed ID: 30822530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.
    Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
    J Opioid Manag; 2010; 6(2):109-16. PubMed ID: 20481175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment strategies for cancer patients with breakthrough pain.
    Casuccio A; Mercadante S; Fulfaro F
    Expert Opin Pharmacother; 2009 Apr; 10(6):947-53. PubMed ID: 19351277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.
    Bossi P; Locati L; Bergamini C; Mirabile A; Granata R; Imbimbo M; Resteghini C; Licitra L
    Oral Oncol; 2014 Sep; 50(9):884-7. PubMed ID: 25001894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
    Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
    J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics.
    Bennett DS; Simon S; Brennan M; Shoemaker SA
    J Opioid Manag; 2007; 3(2):101-6. PubMed ID: 17520989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study.
    Mercadante S; Caraceni A; Cuomo A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond the traditional definition of breakthrough pain: an observational study.
    Gatti A; Gentili M; Iorno V; Mammucari M; Tufaro G; Lazzari M; Sabato AF
    Adv Ther; 2013 Mar; 30(3):298-305. PubMed ID: 23444055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study.
    Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ; Sanz A
    Drugs R D; 2017 Sep; 17(3):419-425. PubMed ID: 28744772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough pain in the management of chronic persistent pain syndromes.
    Webster LR
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study.
    Gatti A; Mediati RD; Reale C; Cuomo A; Vellucci R; Russo G; Costantini A; Canneti A; Luzi M; Mammucari M; Sabato AF
    Adv Ther; 2012 May; 29(5):464-72. PubMed ID: 22622488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
    Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ
    Clin Drug Investig; 2015 Dec; 35(12):815-22. PubMed ID: 26507617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.